New regimen could help fight hepatitis C virus

08/14/2013 | HealthDay News

A German study found interferon-free treatment with a combination of faldaprevir, deleobuvir and ribavirin was effective in a clinical trial involving 362 patients with chronic hepatitis C genotype 1. Depending on dosage and duration of treatment, 52% to 69% of the participants were hepatitis-free three months after therapy.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC